NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE IN
WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED
STATES, AUSTRALIA, CANADA, NEW ZEALAND, JAPAN OR THE REPUBLIC OF
SOUTH AFRICA OR IN ANY OTHER JURISDICTION IN WHICH OFFERS OR SALES
WOULD BE PROHIBITED BY APPLICABLE LAW. THIS ANNOUNCEMENT IS NOT AN
OFFER TO SELL OR A SOLICITATION TO BUY SECURITIES IN ANY
JURISDICTION. NEITHER THIS ANNOUNCEMENT NOR ANYTHING CONTAINED
HEREIN SHALL FORM THE BASIS OF, OR BE RELIED UPON IN CONNECTION
WITH, ANY OFFER OR COMMITMENT WHATSOEVER IN ANY
JURISDICTION.
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION
AS DEFINED IN ARTICLE 7 OF EU REGULATION NO. 596/2014 AS IT FORMS
PART OF DOMESTIC LAW IN THE UNITED KINGDOM BY VIRTUE OF THE
EUROPEAN UNION (WITHDRAWAL) ACT 2018 ("UK MAR"). UPON THE
PUBLICATION OF THIS ANNOUNCEMENT, THIS INSIDE INFORMATION IS NOW
CONSIDERED TO BE IN THE PUBLIC DOMAIN.
9 December 2024
Scancell Holdings plc
("Scancell" or the "Company")
Result of Significantly Oversubscribed
Retail Offer and Total Voting Rights
Scancell Holdings plc (AIM: SCLP),
the developer of novel immunotherapies for the
treatment of cancer, is pleased to confirm, further to
the announcements made on 4 December 2024, the result of its
significantly oversubscribed Retail Offer and Capital Raise at the
Issue Price of 10.5 pence per share. The Company announces that it
has, conditional on Admission, raised aggregate gross proceeds of
approximately £1 million pursuant to the Retail Offer. This is in
addition to the previously announced oversubscribed Placing and
Subscription which had significant participation from both existing
and new healthcare specialist investors. Accordingly, the Company
will issue a total of 9,523,809 new Ordinary Shares at the Issue
Price pursuant to the Retail Offer.
In total, the Placing, Subscription and the
Retail Offer have raised gross proceeds of approximately £11.3
million in aggregate for the Company.
Admission and
Total Voting Rights
Application has been made for the Placing
Shares, the Subscription Shares and the Retail Offer Shares to be
admitted to trading on AIM ("Admission"). Admission is expected to
become effective on or around 10 December 2024.
Upon Admission, the Company's issued ordinary
share capital will consist of 1,036,781,403 Ordinary Shares. The
Company does not hold any Ordinary Shares in treasury. Therefore,
from Admission the total number of Ordinary Shares and voting
rights in the Company will be 1,036,781,403. With effect from
Admission, this figure may be used by Shareholders in the Company
as the denominator for the calculations by which they will
determine if they are required to notify their interest in, or a
change to their interest in, the Company under the FCA's Disclosure
Guidance and Transparency Rules.
The new Ordinary Shares to be issued pursuant
to the Retail Offer will be issued free of all liens, charges and
encumbrances and will, on Admission, rank pari passu in all respects with the
new Ordinary Shares to be issued pursuant to the Placing, the
Subscription and the Company's existing Ordinary Shares.
For the purposes of UK MAR, the person
responsible for arranging for the release of this announcement on
behalf of the Company is Sath Nirmalanathan, Chief Financial
Officer.
Terms used but
not defined in this announcement have the same meaning as set out
in the Company's announcement released at 5:59 pm on 4 December
2024.
Scancell
Holdings plc
|
+44 (0) 20
3709 5700
|
Phil L'Huillier, CEO
Professor Lindy Durrant,
CSO
Dr Jean-Michel Cosséry,
Non-Executive Chairman
|
|
|
Panmure
Liberum Limited (Joint Bookrunner, Joint Broker
and Nominated Advisor)
|
+44 (0) 20
7886 2500
|
Emma Earl, Will Goode, Mark Rogers
(Corporate Finance)
Rupert Dearden (Corporate
Broking)
|
|
WG Partners LLP (Joint Bookrunner and Joint
Broker)
David Wilson, Claes Spang, Satheesh
Nadarajah, Erland Sternby
|
+44 (0) 20
3705 9330
|
|
|
ICR Healthcare
Mary-Jane Elliott, Angela Gray,
Lindsey Neville
|
+44 (0) 20
3709 5700
scancell@icrhealthcare.com
|
Winterflood
Retail Access Platform
|
WRAP@winterflood.com
|
Joe Winkley, Sophia Bechev
|
0203 100
0286
|
|
|
|
|
|
|
Further information on the Company can be found
on its website at www.scancell.co.uk.
The Company's LEI is
2138008RXEG856SNP666.
This announcement should be read in its
entirety. In particular, the information in the "Important Notices" section of the
announcement should be read and understood.
Important
Notices
The content of this announcement, which has
been prepared by and is the sole responsibility of the
Company.
This announcement and the information contained
herein is not for release, publication or distribution, directly or
indirectly, in whole or in part, in or into or from the United
States (including its territories and possessions, any state of the
United States and the District of Columbia (the "United States" or "US")), Australia, Canada, New Zealand,
Japan, the Republic of South Africa, any member state of the EEA or
any other jurisdiction where to do so might constitute a violation
of the relevant laws or regulations of such
jurisdiction.
The Retail Offer Shares have not been and will
not be registered under the US Securities Act of 1933, as amended
(the "US Securities Act")
or under the applicable state securities laws of the United States
and may not be offered or sold directly or indirectly in or into
the United States. No public offering of the Retail Offer Shares is
being made in the United States. The Retail Offer Shares are being
offered and sold outside the United States in "offshore transactions", as defined in,
and in compliance with, Regulation S under the US Securities Act
("Regulation S") to non-US
persons (within the meaning of Regulation S).
This announcement does not constitute an offer
to sell or issue or a solicitation of an offer to buy or subscribe
for Retail Offer Shares in the United States, Australia, Canada,
New Zealand, Japan, the Republic of South Africa, any member state
of the EEA or any other jurisdiction in which such offer or
solicitation is or may be unlawful. No public offer of the
securities referred to herein is being made in any such
jurisdiction.
The distribution of this announcement may be
restricted by law in certain jurisdictions and persons into whose
possession any document or other information referred to herein
comes should inform themselves about and observe any such
restriction. Any failure to comply with these restrictions may
constitute a violation of the securities laws of any such
jurisdiction.
WRAP is a proprietary technology platform owned
and operated by Winterflood Securities Ltd (registered address at
Riverbank House, 2 Swan Lane, London EC4R 3GA; FRN 141455).
Winterflood Securities Ltd ("Winterflood") is authorised and
regulated in the United Kingdom by the Financial Conduct Authority,
is acting exclusively for the Company and for no-one else and will
not regard any other person (whether or not a recipient of this
announcement) as its client in relation to the Retail Offer and
will not be responsible to anyone other than the Company for
providing the protections afforded to its clients, nor for
providing advice in connection with the Retail Offer, Admission and
the other arrangements referred to in this announcement.
The value of Ordinary Shares and the income
from them is not guaranteed and can fall as well as rise due to
stock market movements. When you sell your investment, you may get
back less than you originally invested. Figures refer to past
performance and past performance is not a reliable indicator of
future results. Returns may increase or decrease as a result of
currency fluctuations.
Certain statements in this announcement are
forward-looking statements which are based on the Company's
expectations, intentions and projections regarding its future
performance, anticipated events or trends and other matters that
are not historical facts. These forward-looking statements, which
may use words such as "aim", "anticipate", "believe", "intend",
"estimate", "expect" and words of similar meaning, include all
matters that are not historical facts. These forward-looking
statements involve risks, assumptions and uncertainties that could
cause the actual results of operations, financial condition,
liquidity and dividend policy and the development of the industries
in which the Company's businesses operate to differ materially from
the impression created by the forward-looking statements. These
statements are not guarantees of future performance and are subject
to known and unknown risks, uncertainties and other factors that
could cause actual results to differ materially from those
expressed or implied by such forward-looking statements. Given
those risks and uncertainties, prospective investors are cautioned
not to place undue reliance on forward-looking
statements.
These forward-looking statements speak only as
at the date of this announcement and cannot be relied upon as a
guide to future performance. The Company and Winterflood expressly
disclaim any obligation or undertaking to update or revise any
forward-looking statements contained herein to reflect actual
results or any change in the assumptions, conditions or
circumstances on which any such statements are based unless
required to do so by the Financial Conduct Authority, London Stock
Exchange plc or applicable law.
The information in this announcement is for
background purposes only and does not purport to be full or
complete. None of Winterflood or any of its affiliates, accepts any
responsibility or liability whatsoever for, or makes any
representation or warranty, express or implied, as to this
announcement, including the truth, accuracy or completeness of the
information in this announcement (or whether any information has
been omitted from the announcement) or any other information
relating to the Company or associated companies, whether written,
oral or in a visual or electronic form, and howsoever transmitted
or made available or for any loss howsoever arising from any use of
the announcement or its contents or otherwise arising in connection
therewith. Winterflood and its affiliates, accordingly disclaim all
and any liability whether arising in tort, contract or otherwise
which they might otherwise be found to have in respect of this
announcement or its contents or otherwise arising in connection
therewith.
Any indication in this announcement of the
price at which the Ordinary Shares have been bought or sold in the
past cannot be relied upon as a guide to future performance.
Persons needing advice should consult an independent financial
adviser. No statement in this announcement is intended to be a
profit forecast and no statement in this announcement should be
interpreted to mean that earnings or target dividend per share of
the Company for the current or future financial years would
necessarily match or exceed the historical published earnings or
dividends per share of the Company.
Neither the content of the Company's website
(or any other website) nor the content of any website accessible
from hyperlinks on the Company's website (or any other website) is
incorporated into or forms part of this announcement. The Retail
Offer Shares to be issued or sold pursuant to the Retail Offer will
not be admitted to trading on any stock exchange other than London
Stock Exchange plc.
It is further noted that the Retail Offer is
only open to investors in the United Kingdom who fall within
Article 43 of the Financial Services and Markets Act 2000
(Financial Promotion) Order 2005, as amended (which includes an
existing member of the Company).
Panmure Liberum Limited, which is authorised
and regulated by the FCA in the United Kingdom, is acting as
Nominated Adviser, joint bookrunner and joint broker to the Company
in connection with the Placing. Panmure Liberum Limited has not
authorised the contents of, or any part of, this announcement, and
no liability whatsoever is accepted by Panmure Liberum Limited for
the accuracy of any information or opinions contained in this
announcement or for the omission of any material information. The
responsibilities of Panmure Liberum Limited as the Company's
Nominated Adviser under the AIM Rules for Companies and the AIM
Rules for Nominated Advisers are owed solely to London Stock
Exchange plc and are not owed to the Company or to any director or
shareholder of the Company or any other person, in respect of its
decision to acquire shares in the capital of the Company in
reliance on any part of this announcement, or otherwise.
WG Partners LLP, which is authorised
and regulated by the FCA in the United Kingdom, is acting as joint
bookrunner and joint broker to the Company in connection with the
Placing. WG Partners LLP has not authorised the contents of, or any
part of, this announcement, and no liability whatsoever is accepted
by WG Partners LLP for the accuracy of any information or opinions
contained in this announcement or for the omission of any material
information. No representation or warranty, express or implied, is
or will be made as to, or in relation to, and no responsibility or
liability is or will be accepted by WG Partners LLP or by any of
its affiliates or agents as to, or in relation to, the accuracy or
completeness of this announcement or any other written or oral
information made available to or publicly available to any
interested party or its advisers, and any liability therefor is
expressly disclaimed.